[3-(2-trimethylsilylethoxymethyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]methanol
C13H21N3O2Si — CID 175749387
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-(2-trimethylsilylethoxymethyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]methanol
[3-(2-trimethylsilylethoxymethyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]methanol (PubChem CID 175749387) has the molecular formula C13H21N3O2Si and a molecular weight of 279.42 g/mol. Its IUPAC name is [3-(2-trimethylsilylethoxymethyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]methanol.
Molecular Properties
| Compound Name | [3-(2-trimethylsilylethoxymethyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]methanol |
|---|---|
| PubChem CID | 175749387 |
| Molecular Formula | C13H21N3O2Si |
| Molecular Weight | 279.42 g/mol |
| Exact Mass | 279.14 |
| IUPAC Name | [3-(2-trimethylsilylethoxymethyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]methanol |
| SMILES | C[Si](C)(C)CCOCc1[nH]nc2ncc(CO)cc12 |
| InChI | InChI=1S/C13H21N3O2Si/c1-19(2,3)5-4-18-9-12-11-6-10(8-17)7-14-13(11)16-15-12/h6-7,17H,4-5,8-9H2,1-3H3,(H,14,15,16) |
| InChIKey | JALKHWOXHGGDQK-UHFFFAOYSA-N |
| XLogP | 2.31 |
| TPSA | 71.03 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 279.42 |
| LogP ≤ 5 | 2.31 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175749387 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.